# NextPharma invests €15 million in oral solid dosage manufacturing at Göttingen site

NextPharma completed a €15 million investment at its Göttingen site to increase oral solid dosage form manufacturing and packaging capacity, completed within 12 months.

- Type: Investment
- Announced: 2020-10-09
- Where: Göttingen, Germany
- Status: completed
- Products: oral solid dosage forms
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [NextPharma](https://endata.com/companies/50441.md)

## Sources

- [nextpharma.com](https://nextpharma.com/group/press-and-library/press-detail/nextpharma-invests-eur15-million), 2020-10-09: "we have recently completed a €15 million investment at our Goettingen site."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.